WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today ...

Invivyd, Inc. (NASDAQ:IVVD) shares gained in the premarket session on Monday after the company disclosed a $30 million term loan facility with Silicon Valley Bank (SVB), a division of First Citizens ...

There is currently one antibody available for PrEP in COVID-19 – Invivyd’s Pemgarda (pemivibart) – which was granted Emergency Use Authorization (EUA) in the US in March for adults and ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

CET1 capital ratio 12.81%. Reports Q1 net charge-offs .41%. Chairman and CEO Frank Holding, Jr. said: “Our first quarter financial ...

In a report released today, Jason Goldberg from Barclays maintained a Hold rating on First Citizens BancShares (FCNCA – Research Report), with ...

At close: 25 April at 4:00:00 pm GMT-4 ...